Skip to main content
PZ Cormay S.A. logo

PZ Cormay S.A. — Investor Relations & Filings

Ticker · CRM ISIN · PLCMRAY00029 LEI · 2594006HZJ8OSNK56U87 WAR Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2024-10-13 Legal Proceedings Report
Country PL Poland
Listing WAR CRM

About PZ Cormay S.A.

https://cormaydiagnostics.com/

PZ Cormay S.A. is a manufacturer and distributor of in-vitro diagnostic (IVD) solutions for medical laboratories and clinics. The company develops, produces, and sells a comprehensive portfolio of diagnostic reagents, laboratory analyzers, and quality control systems. Its offerings cater to key diagnostic areas, including clinical chemistry, hematology, and immunoassay. Key product lines feature the Accent series of chemistry analyzers, the Auryx immunoassay system, and the Mythic family of hematology analyzers. The company integrates its extensive experience in reagent manufacturing with advanced Swiss hematology technology to provide reliable, high-performance, and cost-effective diagnostic tools to a global network of distributors and healthcare professionals.

Recent filings

Filing Released Lang Actions
Decyzja Ministra Rozwoju i Technologii w sprawie wywozu przez PZ CORMAY S.A. do Rosji analizatorów hematologicznych - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document text is a formal notification from PZ CORMAY S.A. regarding a refusal by the Minister of Development and Technology to grant permission for the export of hematology analyzers to the Russian Federation, based on EU Regulation No 833/2014 concerning restrictive measures related to Russia's actions destabilizing Ukraine. This concerns a specific regulatory action/sanction impacting the company's operations and future financial results. This fits best under 'Legal Proceedings Report' (LTR) as it details a significant regulatory/governmental action impacting business operations, or potentially 'Regulatory Filings' (RNS) as a general regulatory update. Given the specific nature of the government decision impacting trade/sanctions compliance, LTR is a strong candidate, but RNS is often used for general regulatory compliance notices that aren't lawsuits. Since it is a direct regulatory decision impacting trade, and not a lawsuit, RNS (Regulatory Filings) serves as the most appropriate general category for non-standard regulatory notices that don't fit elsewhere (like DIRS, DIV, etc.). The document is short and is an announcement of an event/decision, not a comprehensive report.
2024-10-13 Polish
zal04_4._Raport_z_przegladu_PZ_CORMAY_S.A._I_polrocze_2024.pdf
Audit Report / Information Classification · 100% confidence The document is explicitly titled "RAPORT BIEGŁEGO REWIDENTA z przeglądu śródrocznego skróconego sprawozdania finansowego" (Independent Auditor's Report on the review of the condensed interim financial statements). It covers the period from January 1, 2024, to June 30, 2024, which is a six-month period, making it an interim report review. The definition for Audit Report / Information (AR) states: "Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)." This document is a formal report from an auditor regarding an interim financial statement review, fitting the 'AR' category perfectly, as it is not the full Annual Report (10-K) or a mere announcement of a report (RPA/RNS). H1 2024
2024-09-20 Polish
zal02_3._Raport_z_przegladu_GK_CORMAY_I_polrocze_2024.pdf
Audit Report / Information Classification · 99% confidence The document is explicitly titled "RAPORT BIEGŁEGO REWIDENTA z przeglądu śródrocznego skróconego skonsolidowanego sprawozdania finansowego" (Independent Auditor's Report on the review of the condensed interim consolidated financial statements). It covers the period from January 1, 2024, to June 30, 2024, and concludes with a formal opinion based on a review, not a full audit. This clearly indicates it is an Audit Report/Information related to interim financial statements. The definition for 'Audit Report / Information (Code: AR)' covers 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. Since this is an auditor's report on interim financials, AR is the most appropriate classification, distinguishing it from a full 10-K or a general Interim Report (IR). The document length (4094 chars) is substantial enough to be the report itself, not just an announcement of publication. H1 2024
2024-09-20 Polish
zal01_2._Sprawozdanie_Zarzadu_GK_CORMAY_I_polrocze_2024.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a 'Sprawozdanie Zarządu' (Management Report) for the first half of 2024 for Grupa Kapitałowa CORMAY. It contains detailed management commentary, analysis of business performance, risk factors, and financial data for the interim period. While it is a management report, it serves as the core component of the interim financial reporting package required by regulatory authorities for listed companies. According to the definitions, this fits the 'Interim / Quarterly Report' (IR) category as it provides comprehensive analysis and financial context for a period shorter than a full fiscal year. H1 2024
2024-09-20 Polish
zal03_1._Sprawozdania_finansowe_GK_CORMAY_PZ_CORMAY_S.A_I_polrocze_2024.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Śródroczne skrócone skonsolidowane sprawozdanie finansowe' (Interim condensed consolidated financial report) for the first half of 2024. It contains detailed financial statements (profit and loss, cash flow, financial position) and extensive explanatory notes. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-20 Polish
Zawarcie umowy pomiędzy PZ CORMAY S.A. a Lubelską Agencją Wspierania Przedsiębiorczości w sprawie dofinansowania udziału PZ CORMAY S.A. w targach sprzętu medycznego Medlab Middle East w Dubaju w 20...
Capital/Financing Update Classification · 95% confidence The document is very short (889 characters) and appears to be a formal announcement regarding the finalization of a grant/subsidy agreement for participation in an international medical equipment fair (Medlab Middle East). It references a previous current report and details the approved funding amount and project cost. This type of announcement, concerning specific financing or grant activities, fits best under the 'Capital/Financing Update' category, as it details the securing of external funds for a specific business activity (international expansion/participation). It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific announcement about securing funding/subsidy, which aligns with the definition of Capital/Financing Update (CAP).
2024-08-19 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.